NCT05453071 The Effect of Cognitive Exercise Therapy Approach in Individuals With Systemic Sclerosis Status COMPLETED Phase NA
NCT05345795 Interstitial Lung Disease Trajectories in Patients With Systemic Sclerosis Status RECRUITING Phase N/A
NCT05339087 Efficacy and Safety of Riociguat in Incipient Pulmonary Vascular Disease as an Indicator for Early PAH Status TERMINATED Phase PHASE2
NCT05300932 A Study Evaluating the Efficacy and Safety of Baricitinib in Systemic Sclerosis Status ACTIVE_NOT_RECRUITING Phase PHASE4
NCT05298358 RIC alloBMT With Post-transplant Cyclophosphamide for Refractory Systemic Sclerosis Status TERMINATED Phase PHASE1
NCT05297474 Structural and Functional Impairment of Multiple Organs in Patients With Systemic Sclerosis: A MR Imaging Study Status UNKNOWN Phase N/A
NCT05273138 Analysis of Dermal Fibroblasts and Immune Cells During Systemic Sclerosis Status RECRUITING Phase N/A
NCT05236491 COvid-19 Vaccine Booster in Immunocompromised Rheumatic Diseases Status UNKNOWN Phase PHASE2/PHASE3
NCT05214794 An Open-label, Phase 2 Study to Assess the Efficacy and Safety of Nemolizumab in Subjects With Systemic Sclerosis Status COMPLETED Phase PHASE2
NCT05214014 Treatment of Systemic Sclerosis With Autologous Regulatory Т-cells Status UNKNOWN Phase PHASE1/PHASE2
NCT05204784 Rheopheresis for Raynaud's and Digital Ulcers in Systemic Sclerosis Status UNKNOWN Phase NA
NCT05198557 A Study of MT-0551 in Patients With Systemic Sclerosis Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05177471 Efficacy and Safety of JAK Inhibitors in Systemic Sclerosis-associated Interstitial Lung Disease Status WITHDRAWN Phase N/A
NCT05177380 Efficacy of a Personalized Rehabilitation Program of Facial Involvement in Systemic Sclerosis Status UNKNOWN Phase NA
NCT05108857 PET Imaging of Systemic Sclerosis Using FDG and 68Ga-DOTA-Siglec-9 Status ENROLLING_BY_INVITATION Phase N/A
NCT05103553 What is the Optimal Follow-up for Patients With Systemic Sclerosis? Status NOT_YET_RECRUITING Phase NA
NCT05098704 Preventive Effect of Clopidogrel on the Systemic Sclerosis Development Risk Status RECRUITING Phase PHASE2/PHASE3